MtvR is a global small noncoding regulatory RNA in Burkholderia cenocepacia

Journal of Bacteriology

Volumn 195, Issue 16, 2013, Pages 3514-3523

  Ramos, Christian G ^a   Grilo, André M ^a   Da Costa, Paulo J P ^a   Feliciano, Joana R ^a   Leitão, Jorge H ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; UNTRANSLATED RNA;

5' UNTRANSLATED REGION; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BIOINFORMATICS; BURKHOLDERIA CENOCEPACIA; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; NONHUMAN; PRIORITY JOURNAL; REGULATORY RNA SEQUENCE;

ANTI-BACTERIAL AGENTS; BIOFILMS; BURKHOLDERIA CENOCEPACIA; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; RNA, BACTERIAL; RNA, MESSENGER; RNA, UNTRANSLATED; STRESS, PHYSIOLOGICAL;

EID: 84880969985     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00242-13     Document Type: Article

References (30)

1. Gottesman S. 2005. Micros for microbes: non-coding regulatory RNAs in bacteria. Trends Genet. 21:399-404.
2. Papenfort K, Vogel J. 2010. Regulatory RNA in bacterial pathogens. Cell Host Microbe 8:116-127.
3. Vogel J, Luisi BF. 2011. Hfq and its constellation of RNA. Nat. Rev. Microbiol. 9:578-589.
4. Richards GR, Vanderpool CK. 2011. Molecular call and response: the physiology of bacterial small RNAs. Biochim. Biophys. Acta 1809:525-531.
5. Sun X, Zhulin I, Wartell RM. 2002. Predicted structure and phyletic distribution of the RNA-binding protein Hfq. Nucleic Acids Res. 30:3662-3671.
6. Ramos CG, Sousa SA, Grilo AM, Feliciano JR, Leitão JH. 2011. The second RNA chaperone, Hfq2, is also required for survival under stress and full virulence of Burkholderia cenocepacia J2315. J. Bacteriol. 193: 1515-1526.
7. Sousa SA, Ramos CG, Moreira LM, Leitão JH. 2010. The hfq gene is required for stress resistance and full virulence of Burkholderia cepacia to the nematode Caenorhabditis elegans. Microbiology 156:896-908.
8. Bazzini S, Udine C, Riccardi G. 2011. Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium. Appl. Microbiol. Biotechnol. 92:887-895.
9. Leitão JH, Sousa SA, Ferreira AS, Ramos CG, Silva IN, Moreira LM. 2010. Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species. Appl. Microbiol. Biotechnol. 87:31-40.
10. Drevinek P, Mahenthiralingam E. 2010. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin. Microbiol. Infect. 16:821-830.
11. Loutet SA, Valvano MA. 2010. A decade of Burkholderia cenocepacia virulence determinant research. Infect. Immun. 78:4088-4100.
12. Coenye T, Drevinek P, Mahenthiralingam E, Shah SA, Gill RT, Vandamme P, Ussery DW. 2007. Identification of putative noncoding RNA genes in the Burkholderia cenocepacia J2315 genome. FEMS Microbiol. Lett. 276:83-92.
13. Holden MTG, Seth-Smith HMB, Crossman LC, Sebaihia M, Bentley SD, Cerdeno-Tarraga AM, Thomson NR, Bason N, Quail MA, Sharp S, Cherevach I, Churcher C, Goodhead I, Hauser H, Holroyd N, Mungall K, Scott P, Walker D, White B, Rose H, Iversen P, Mil-Homens D, Rocha EPC, Fialho AM, Baldwin A, Dowson C, Barrell BG, Govan JR, Vandamme P, Hart CA, Mahenthiralingam E, Parkhill J. 2009. The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J. Bacteriol. 191:261-277.
14. Coenye T, Van Acker H, Peeters E, Sass A, Buroni S, Riccardi G, Mahenthiralingam E. 2011. Molecular mechanisms of chlorhexidine tol-erance in Burkholderia cenocepacia biofilms. Antimicrob. Agents Chemother. 55:1912-1919.
15. Ramos CG, Grilo AM, da Costa PJP, Leitão JH. 2013. Experimental identification of small non-coding regulatory RNAs in the opportunistic human pathogen Burkholderia cenocepacia J2315. Genomics 101:139-148.
16. Ramos CG, da Costa PJP, Döring G, Leitão JH. 2012. The novel cisencoded small RNA h2cR is a negative regulator of hfq2 in Burkholderia cenocepacia. PLoS One 7:e47896. doi:10.1371/journal.pone.0047896.
17. Zhou Y, Gottesman S. 1998. Regulation of proteolysis of the stationaryphase sigma factor RpoS. J. Bacteriol. 180:1154-1158.
18. Leitão JH, Sousa SA, Cunha MV, Salgado MJ, Melo-Cristino J, Barreto MC, Sá-Correia I. 2008. Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center. Eur. J. Clin. Microbiol. Infect. Dis. 27:1101-1111.
19. Cunha MV, Sousa SA, Leitão JH, Moreira LM, Videira PA, Sá-Correia I. 2004. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J. Clin. Microbiol. 42:3052-3058.
20. Sousa SA, Ramos CG, Almeida F, Meirinhos-Soares L, Wopperer J, Schwager S, Eberl L, Leitão JH. 2008. Burkholderia cenocepacia J2315 acyl carrier protein: a potential target for antimicrobials development? Microb. Pathog. 45:331-336.
21. Amann RI, Krumholz L, Stahl DA. 1990. Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. J. Bacteriol. 172:762-770.
22. Zhao Y, Li H, Hou Y, Cha L, Cao Y, Wang L, Ying X, Li W. 2008. Construction of two mathematical models for prediction of bacterial sRNA targets. Biochem. Biophys. Res. Commun. 372:346-350.
23. Lefebre MD, Valvano MA. 2002. Construction and evaluation of plasmid vectors optimized for constitutive and regulated gene expression in Burkholderia cepacia complex isolates. Appl. Environ. Microbiol. 68:5956-5964.
24. Hamad MA, Skeldon AM, Valvano MA. 2010. Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay. Appl. Environ. Microbiol. 76:3170-3176.
25. Rehmsmeier M, Steffen P, Höchsmann M, Giegerich R. 2004. Fast and effective prediction of microRNA/target duplexes. RNA 10:1507-1517.
26. Chabelskaya S, Gaillot O, Felden B. 2010. A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule. PLoS Pathog. 6:e1000927. doi:10.1371/journal.ppat.1000927.
27. Vecerek B, Moll I, Blasi U. 2005. Translational autocontrol of the Escherichia coli hfq RNA chaperone gene. RNA 11:976-984.
28. Vecerek B, Rajkowitsch L, Sonnleitner E, Schroeder R, Blasi U. 2008. The C-terminal domain of Escherichia coli Hfq is required for regulation. Nucleic Acids Res. 36:133-143.
29. Zuker M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406-3415.
30. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. document M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA.